Philip P. Boudreau
At a glance: Philip P. Boudreau is CFO at Abbott Laboratories (ABT). Their latest SEC Form 4, filed Apr 27, 2026, reported a purchase of $201K. On file: 1 purchase line ($201K) and 0 sale lines ($0).
Disclosed holdings: about $229K of ABT stock: 2,200 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Apr 27, 2026), valued at the Nov 20, 2026 close of $104.17. This counts only ABT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CFO at Abbott Laboratories (ABT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
Every purchase since 2026
From the SEC's insider data sets: each open-market buy by Philip P. Boudreau, matched to how the stock did over the next 90 days against the S&P 500.
1 of 1 buy beat the S&P 500 (100%), median +8.0% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| ABT | Apr 28, 2026 | +8.0% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 27SEC | ABTAbbott LaboratoriesFirst buyNew position | Buy | 2,200new position | $91.50 | $201K | +13.8% |
- Buy
CFO Philip P Boudreau bought $201K of ABT at $91.50 — first open-market purchase in our records; opens a new position.
Follow Philip P. Boudreau
Get one email when Philip P. Boudreau files a new purchase or sale. Free.
At most one email a day about Philip P. Boudreau, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.